Comparative evaluation of semaphorin‐4D, peptidylarginine deiminase‐2, and matrix metalloproteinase‐8 levels of gingival crevicular fluid in periodontally healthy and Stage III periodontitis smoker and non‐smoker patients before and after non‐surgical periodontal therapy
Journal of Periodontology · 2024
DOI: 10.1002/jper.23-0324 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Periodontology, 2024. Verfasst von Aishwarya S Ikhar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology and Implant Dentistry, VSPM Dental College and Research Centre, Nagpur, Maharashtra, India. Hauptthemen laut MEDLINE: Gingival Crevicular Fluid, Semaphorins, Matrix Metalloproteinase 8, Antigens, CD. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Background
This study was designed to assess the influence of non‐surgical periodontal therapy (NSPT) on gingival crevicular fluid (GCF) levels of semaphorin‐4D (SEMA‐4D), peptidylarginine deiminase‐2 (PAD‐2), and matrix metalloproteinase‐8 (MMP‐8) levels in periodontally healthy, Stage III periodontitis non‐smoker and smoker patients.
Methods
Sixty patients were equally divided into three groups, Group I: Periodontally healthy, Group II: Non‐smokers with Stage III periodontitis, and Group III: Smokers with Stage III periodontitis. The patients underwent NSPT with clinical and biochemical parameters examined at baseline and 3 months post therapy. GCF was collected for levels of SEMA‐4D, PAD‐2, and MMP‐8 through enzyme‐linked immunosorbent assay (ELISA).
Results
Greater values of PPD (8.06 ± 0.19 mm), CAL (8.94 ± 0.19 mm), PI (2.58 ± 0.19) while lower PBI (1.39 ± 0.19%) and GI (1.72 ± 0.19) scores were seen in Group III as compared to Group II, which reduced significantly from baseline to 3 months in both the groups after NSPT. Minimum values of SEMA‐4D, PAD‐2, and MMP‐8 levels in GCF were seen for Group I, which increased incrementally to Group II and III. Also, among Group II and III the SEMA‐4D, PAD‐2, and MMP‐8 levels in GCF reduced from baseline to 3 months indicating a favorable response within the tissues.
Conclusion
Greater levels in GCF of Levels of SEMA‐4D, PAD‐2, and MMP‐8 in Group II and III, which reduced significantly post NSPT, implied that these biomarkers play a pivotal role in the inflammatory process and can be utilized for early diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontology and Implant Dentistry, VSPM Dental College and Research Centre, Nagpur, Maharashtra, India.
- Department of Oral and Maxillofacial Surgery, VSPM Dental College and Research Centre, Nagpur, Maharashtra, India.
ORCID-Profile: Rajashri A Kolte, Abhay P Kolte, Dhanashree G Ghoderao
Zitieren
APA
Ikhar, A. S., Kolte, R. A., Kolte, A. P., Rathi, P. R., Ghoderao, D. G., & Dahake, R. N. (2024). Comparative evaluation of semaphorin‐4D, peptidylarginine deiminase‐2, and matrix metalloproteinase‐8 levels of gingival crevicular fluid in periodontally healthy and Stage III periodontitis smoker and non‐smoker patients before and after non‐surgical periodontal therapy. Journal of Periodontology. https://doi.org/10.1002/jper.23-0324
Vancouver
Ikhar AS, Kolte RA, Kolte AP, Rathi PR, Ghoderao DG, Dahake RN. Comparative evaluation of semaphorin‐4D, peptidylarginine deiminase‐2, and matrix metalloproteinase‐8 levels of gingival crevicular fluid in periodontally healthy and Stage III periodontitis smoker and non‐smoker patients before and after non‐surgical periodontal therapy. Journal of Periodontology. 2024. doi:10.1002/jper.23-0324
BibTeX
@article{Ikhar2024,
author = {Ikhar, Aishwarya S and Kolte, Rajashri A and Kolte, Abhay P and Rathi, Prachi R and Ghoderao, Dhanashree G and Dahake, Rahul N},
title = {Comparative evaluation of semaphorin‐4D, peptidylarginine deiminase‐2, and matrix metalloproteinase‐8 levels of gingival crevicular fluid in periodontally healthy and Stage III periodontitis smoker and non‐smoker patients before and after non‐surgical periodontal therapy},
journal = {Journal of Periodontology},
year = {2024},
doi = {10.1002/jper.23-0324}
}
EUVIMED